OppenheimerFunds’s Natus Medical Inc NTUS Stock Holding History

OppenheimerFunds’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$272K	Buy	10,736 +2,509	+30%	+$74.9K	﹤0.01%	1588
2018 Q4	$280K	Sell	8,227 -1,107	-12%	-$36K	﹤0.01%	1600
2018 Q3	$333K	Buy	9,334 +54	+0.6%	+$1.91K	﹤0.01%	1617
2018 Q2	$320K	Sell	9,280 -135	-1%	-$4.73K	﹤0.01%	1599
2018 Q1	$317K	Buy	9,415 +959	+11%	+$30.4K	﹤0.01%	1571
2017 Q4	$323K	Sell	8,456 -697	-8%	-$27.8K	﹤0.01%	1673
2017 Q3	$343K	Sell	9,153 -408	-4%	-$14.4K	﹤0.01%	1669
2017 Q2	$357K	Buy	9,561 +1,535	+19%	+$55.5K	﹤0.01%	1647
2017 Q1	$315K	Buy	8,026 +1,689	+27%	+$63.4K	﹤0.01%	1692
2016 Q4	$221K	Buy	+6,337	New	+$249K	﹤0.01%	1715

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OppenheimerFunds's NTUS Position: Q1 2019 in Review

OppenheimerFunds increased its Natus Medical Inc (NTUS) stake by 30% in Q1 2019, buying an estimated $74.9K and bringing the position to 10,736 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

OppenheimerFunds first reported a position in NTUS in Q4 2016 and has held it in 10 quarters since. The position peaked at $357K in Q2 2017. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

OppenheimerFunds held 10,736 shares of Natus Medical Inc worth $272K as of Q1 2019.
OppenheimerFunds bought 2,509 Natus Medical Inc shares in Q1 2019, an estimated $74.9K.
Natus Medical Inc made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1588 holding.
OppenheimerFunds first reported a position in Natus Medical Inc in Q4 2016 and has held it in 10 quarters since.
OppenheimerFunds's Natus Medical Inc position peaked at $357K in Q2 2017.
168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.